molecular neural interfaces

# molecular neural interfaces **Entity class:** Technology, method, or technical system **Collections:** [[collections/War With Empire|War With Empire]] · [[collections/Neurotech|Neurotech]] ## Definition **molecular neural interfaces** is a technology, method, or technical system. [[wiki/Merge Labs|Merge Labs]] is associated with **molecular neural interfaces**. The entry centers on the technology's mechanism, implementation, applications, and technical lineage, keeping demonstrated capability separate from projected deployment. Dates, quantities, and named relationships retain their source-qualified status in the sections below. ## Relationships  This entry is routed through [[collections/Neurotech|Neurotech]], [[collections/Consciousness Continuity|Consciousness Continuity]], and [[collections/War With Empire|War With Empire]]. Its source context is developed in [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]], [[articles/The Next Interface Layer|The Next Interface Layer]], and [[articles/The Magic Kingdom and the Managed State|The Magic Kingdom and the Managed State]]. Status-qualified source edges are preserved in the terminal Research Edges section. ### Technology and research relationships - [[wiki/Merge Labs|Merge Labs]] is associated with **molecular neural interfaces**.  ## Research Edges  #### Interface and soft-sovereignty graph patch — 2026-09-10 **Collections:** [[collections/War With Empire|War With Empire]] · [[collections/Neurotech|Neurotech]] **Relationship source:** [[research/Interface and Soft Sovereignty Ecosystem Relationship Graph - 2026-09-10|Interface and Soft Sovereignty Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/The Next Interface Layer|The Next Interface Layer]] · [[articles/The Magic Kingdom and the Managed State|The Magic Kingdom and the Managed State]] #### Incoming typed edges - **Edge 518 — [[wiki/Merge Labs|Merge Labs]] `technical_strategy` → this entry** — **VERIFIED**; evidence `OPENAI_MERGE`.  ## Research Inferences  These entries translate the forward-looking register in [[research/Research Inferences|Research Inferences]] into ordinary wiki prose. The tier labels apply to the inference, not automatically to every factual anchor inside it. The interpretive frame comes from [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. ### Field-addressed and molecular interfaces - **INF-0026 — Strongly indicated.** Merge Labs joins ultrasound hardware from Forest Neurotech to Mikhail Shapiro's acoustic-biomolecular line at Caltech, which is the first time the field half and the receptor half of a field-addressed interface have been capitalized inside one company. The composite — sensitize, then address — is what removes surgery from the bandwidth equation. - **Attractor routes:** [[wiki/Merge Labs|Merge Labs]] · [[wiki/Caltech|Caltech]] - **INF-0027 — Established.** Sonogenetics works by installing mechanosensitive channels so that acoustic pressure becomes an ionic event in a chosen cell population. Selectivity is therefore a genetic property and focality an acoustic one, and the two can be improved independently, which is why this architecture scales differently from electrodes. - **Attractor routes:** [[wiki/Merge Labs|Merge Labs]] · [[wiki/DARPA N3|DARPA N3]] - **INF-0028 — Strongly indicated.** A magnetostrictive core inside a piezoelectric shell converts a magnetic field that passes the skull unattenuated into a local electric field that neurons answer. The particle is a field translator, and its existence means depth access does not require a hole — it requires distribution. - **Attractor routes:** [[wiki/Sakhrat Khizroev|Sakhrat Khizroev]] · [[wiki/Merge Labs|Merge Labs]] - **INF-0029 — Analytic.** Optogenetics gives cell-type specificity but is bounded by the optical scattering length of tissue; magnetic and acoustic modalities give depth but coarser selectivity. Every serious non-surgical interface program is now attempting the same synthesis of the two, and whichever pairing lands first sets the modality standard for decades. - **Attractor routes:** [[wiki/Magnetogenetics|Magnetogenetics]] · [[wiki/Optogenetics|Optogenetics]] - **INF-0030 — Established.** DARPA's N3 program treated magnetic, optical, and acoustic access as one design space and funded them in parallel rather than picking a winner. That structure is the clearest evidence that the state's objective was modality-independent non-surgical access, and the program's outputs are now distributed across multiple private companies. - **Attractor routes:** [[wiki/DARPA N3|DARPA N3]] · [[wiki/MOANA|MOANA]] - **INF-0031 — Plausible.** Every molecular interface requires a delivery vector, which makes AAV capsid engineering an interface technology rather than a gene-therapy technology. Capsid tropism determines which cells can be addressed, so the vector library is functionally the addressing scheme of the future nervous-system network. - **Attractor routes:** [[wiki/Neural Interface|Neural Interface]] · [[wiki/Merge Labs|Merge Labs]] - **INF-0032 — Established.** Focused ultrasound with microbubbles opens the blood-brain barrier transiently and reversibly at a chosen location, which makes systemic delivery locally targetable. That single capability converts the vasculature into a delivery bus addressed by an external transducer. - **Attractor routes:** [[wiki/next-generation focused ultrasound neuromodulation and recording|next-generation focused ultrasound neuromodulation and recording]] · [[wiki/Ultrasound Neurotechnology|Ultrasound Neurotechnology]] - **INF-0033 — Analytic.** Functional ultrasound reads blood-flow dynamics, a proxy signal with seconds-scale physics, and any interface built on it inherits that time constant. The forward path is not faster hemodynamics but hybrid operation — acoustic read of slow state, molecular read of fast events. - **Attractor routes:** [[wiki/Functional Ultrasound|Functional Ultrasound]] · [[wiki/next-generation focused ultrasound neuromodulation and recording|next-generation focused ultrasound neuromodulation and recording]] - **INF-0034 — Plausible.** A one-time sensitizing edit followed by a lifetime of external field addressing inverts the economics of neural interfacing: the expensive, risky step happens once and the hardware upgrades stay outside the body. This is the configuration most likely to reach populations rather than patients. - **Attractor routes:** [[wiki/Neural Interface|Neural Interface]] · [[wiki/Merge Labs|Merge Labs]] - **INF-0035 — Plausible.** Nanoscale devices inside tissue need a communication layer, and molecular and terahertz channels are the two candidates with the right length scales. The body-internal network is being specified now in exactly the way IP was specified before there was traffic to carry. - **Attractor routes:** [[wiki/Sakhrat Khizroev|Sakhrat Khizroev]] · [[wiki/Merge Labs|Merge Labs]] - **INF-0036 — Established.** Optogenetic vision restoration has already produced partial clinical results in humans, which means installing a light-responsive receptor in a human nervous system is a completed procedure rather than a proposal. Every write-side architecture inherits that precedent. - **Attractor routes:** [[wiki/Optogenetics|Optogenetics]] · [[wiki/Optogenetics and Chemogenetics|Optogenetics and Chemogenetics]] - **INF-0037 — Strongly indicated.** Voltage indicators read the electrical event directly rather than its calcium shadow, trading signal-to-noise for temporal fidelity. As indicator brightness improves, optical readout crosses into spike-timing resolution and becomes a genuine alternative to electrodes at scale. - **Attractor routes:** [[wiki/Voltage Imaging|Voltage Imaging]] · [[wiki/Calcium Imaging|Calcium Imaging]] - **INF-0038 — Analytic.** Acoustoelectric sensing uses ultrasound to tag the location of electrical activity, recovering spatial precision from a diffuse electrical measurement. It is the only current approach that promises electrode-grade localization with no electrode, and British state research funding is upstream of it. - **Attractor routes:** [[wiki/Neural Interface|Neural Interface]] · [[wiki/next-generation focused ultrasound neuromodulation and recording|next-generation focused ultrasound neuromodulation and recording]] - **INF-0039 — Plausible.** Field-plus-receptor architectures make addressable population size a function of expression pattern rather than of implant geometry. If expression can be driven across a cortical region, the addressable channel count jumps by orders of magnitude in a single step rather than by iterative device generations. - **Attractor routes:** [[wiki/DARPA N3|DARPA N3]] · [[wiki/Merge Labs|Merge Labs]] - **INF-0040 — Unresolved.** Whether magnetoelectric particles can be distributed with sufficient uniformity to address a functionally meaningful population is the open technical question for that modality. Resolution comes from imaging studies of particle biodistribution at scale, not from stimulation demonstrations. - **Attractor routes:** [[wiki/Sakhrat Khizroev|Sakhrat Khizroev]] · [[wiki/DARPA N3|DARPA N3]] - **INF-0041 — Analytic.** A sensitized cell population is a permanent modification even when the hardware is external, which relocates the irreversibility from the device to the genome. Consent frameworks written for implants do not describe this situation, and the gap will be discovered clinically before it is described legally. - **Attractor routes:** [[wiki/Neural Interface|Neural Interface]] · [[wiki/DARPA N3|DARPA N3]] - **INF-0042 — Strongly indicated.** A non-surgical read/write channel and a high-fidelity world model are complementary halves of the same product: one supplies the environment, the other the participant. The teams pursuing them are already capitalized by the same investor set, which shortens the integration timeline considerably. - **Attractor routes:** [[wiki/World Simulation|World Simulation]] · [[wiki/Merge Labs|Merge Labs]] - **INF-0043 — Established.** Shapiro's acoustic biomolecules moving from a Caltech laboratory into a venture-backed company with OpenAI as research collaborator is a complete technology-transfer event with a named date. Trace the researcher and the capability's location is always known. - **Attractor routes:** [[wiki/Caltech|Caltech]] · [[wiki/Merge Labs|Merge Labs]] - **INF-0044 — Plausible.** Transcranial focused ultrasound already modulates deep structures without genetic modification, which gives the modality a clinical on-ramp independent of sonogenetics. The therapy indication funds the hardware, and the hardware is the same hardware the interface needs. - **Attractor routes:** [[wiki/next-generation focused ultrasound neuromodulation and recording|next-generation focused ultrasound neuromodulation and recording]] · [[wiki/Ultrasound Neurotechnology|Ultrasound Neurotechnology]] - **INF-0045 — Plausible.** Molecular recorders that write neural activity into DNA inside the cell would remove bandwidth from the readout path entirely: the record is made locally and read once, later, by sequencing. That inverts the entire acquisition architecture and makes whole-population recording a sequencing-cost problem. - **Attractor routes:** [[wiki/next-generation focused ultrasound neuromodulation and recording|next-generation focused ultrasound neuromodulation and recording]] · [[wiki/Optogenetics and Chemogenetics|Optogenetics and Chemogenetics]] - **INF-0046 — Analytic.** Enhancer-driven expression lets a modality address a cell type rather than a volume, which is a form of logical addressing overlaid on physical space. The nervous system becomes a network with types as addresses, and that is a far more powerful abstraction than coordinates. - **Attractor routes:** [[wiki/Cell Type|Cell Type]] · [[wiki/Optogenetics and Chemogenetics|Optogenetics and Chemogenetics]] - **INF-0047 — Strongly indicated.** The peripheral nervous system is accessible without craniotomy and carries organ-regulatory traffic, which makes it the first place where continuous closed-loop control of the body's internal state becomes routine. Central interfaces will inherit a control theory developed peripherally. - **Attractor routes:** [[wiki/Neural Interface|Neural Interface]] · [[wiki/Magnetogenetics|Magnetogenetics]] - **INF-0048 — Plausible.** As modalities multiply, the durable asset stops being the transducer and becomes the signal format and the model that consumes it. Whoever defines the representation that all modalities target owns the layer above every device generation. - **Attractor routes:** [[wiki/DARPA N3|DARPA N3]] · [[wiki/Merge Labs|Merge Labs]] - **INF-0049 — Analytic.** Capital from interactive entertainment arriving in a non-surgical interface company signals which market is expected to absorb the technology at volume. Medical indication is the regulatory route; the addressable population is being underwritten by people who sell experiences. - **Attractor routes:** [[wiki/Ultrasound Neurotechnology|Ultrasound Neurotechnology]] · [[wiki/Sakhrat Khizroev|Sakhrat Khizroev]] - **INF-0050 — Plausible.** If the receptor layer is genetic and the field layer is external, the interface upgrades on a hardware cadence while the biological substrate stays constant. That is the first architecture in neurotechnology with a Moore's-law-shaped improvement path, because the fast-moving component is no longer inside the patient. - **Attractor routes:** [[wiki/Merge Labs|Merge Labs]] · [[wiki/Magnetogenetics|Magnetogenetics]]